Insights and News

Heuristic evaluation: what, how and why

How can digital enhance the support tools provided for patients with rare disease?
In the world of rare and ultra rare diseases, there is huge scope for digital tools, services and platforms to enhance the patient experience. Recently, we’ve noticed that increasing numbers of pharmaceutical companies are looking to improve and augment their patient-facing digital tools in order to offer a more holistic approach to rare disease treatment, and help empower patients to manage their condition. Here, we take a look at the possible role and benefits of an increased focus on digital in this field.